drugset / Trial / NCT02583165
A Study in Adult Subjects With Select Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and tolerability of MEDI1873 in adult subjects with selected advanced solid tumors.
Timeline
- Start
- 2015-11-09
- Primary completion
- 2018-12-19
- Completion
- 2018-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EFGIVANERMIN ALFA | Protein / enzyme biologic | — | Intravenous |